2014
DOI: 10.2217/nnm.14.74
|View full text |Cite
|
Sign up to set email alerts
|

Nanomedicine Strategies for Targeting Skin Inflammation

Abstract: Topical treatment of skin diseases is an attractive strategy as it receives high acceptance from patients, resulting in higher compliance and therapeutic outcomes. Recently, the use of variable nanocarriers for dermal application has been widely explored, as they offer several advantages compared with conventional topical preparations, including higher skin penetration, controlled and targeted drug delivery and the achievement of higher therapeutic effects. This article will focus on skin inflammation or derma… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
20
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 44 publications
(21 citation statements)
references
References 102 publications
1
20
0
Order By: Relevance
“…Though nanoparticle induced immunogenicity is desirable in certain instances -vaccine formulations for example 65 , 66 - further immune cell activation in inflammatory skin diseases is not. 67 Indeed, the bio- and immune- compatibility of the tNGs towards skin LCs is essential to their use in the topical treatment of a wide range of skin diseases.…”
Section: Resultsmentioning
confidence: 99%
“…Though nanoparticle induced immunogenicity is desirable in certain instances -vaccine formulations for example 65 , 66 - further immune cell activation in inflammatory skin diseases is not. 67 Indeed, the bio- and immune- compatibility of the tNGs towards skin LCs is essential to their use in the topical treatment of a wide range of skin diseases.…”
Section: Resultsmentioning
confidence: 99%
“…Whilst it is probable that penetrance of nanoparticles into the viable epidermis changes considerably when applied to inflamed or lesional skin, surprisingly few studies have investigated the use of drug loaded nanoparticles in the skin diseases for which they are intended. Reasons for this apparent lack include the limited availability of diseased human skin for experimental purposes and the popularity of animal models in the assessment of nanoparticle mediated anti-inflammatory effects [18]. Rodent skin however demonstrates major anatomical and physiological differences relative to human skin, something that skin models aim to overcome [19][20][21].…”
Section: Introductionmentioning
confidence: 99%
“…Liposomes are phospholipid bilayer systems with an aqueous core, which may be loaded with hydrophilic drugs in the core or lipophilic drugs trapped within the phospholipid bilayers [17,57]. Concerning their phospholipid constitution, liposomes are able to interact with the stratum corneum's lipids, allowing MXD skin permeation, or through the hair follicles, creating MXD's depots [58].…”
Section: Liposomesmentioning
confidence: 99%
“…Liposomes are highly biocompatible and biodegradable, remaining in blood circulation for extended periods of time. Nonetheless, their applicability is restricted due to stability issues, namely aggregation, drug leakage, hydrolysis and particle size alterations [57,59]. MXD-loaded liposomes reportedly enhanced skin permeation through the stratum corneum pathway and depot formation with significant improvements, namely MXD sustained release and targeting features (Table 2).…”
Section: Liposomesmentioning
confidence: 99%